$MMI
Marcus & Millichap, Inc. Stock $mmi

$mmi Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000157873223000048 Filed on November 03, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$166.2M	$162.0M
YoY Change	-36.66%	-49.97%
Cost Of Revenue	$105.4M	$104.6M
YoY Change	-41.66%	-51.88%
Gross Profit	$60.82M	$57.40M
YoY Change	-25.58%	-46.09%
Gross Profit Margin	36.58%	35.43%
Selling, General & Admin	$74.70M	$69.19M
YoY Change	2.85%	-5.22%
% of Gross Profit	122.83%	120.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.315M	$2.400M
YoY Change	2.35%	41.18%
% of Gross Profit	5.45%	4.18%
Operating Expenses	$78.02M	$177.5M
YoY Change	2.83%	-39.49%
Operating Profit	-$17.20M	-$15.43M
YoY Change	-393.68%	-150.51%
Interest Expense	-$216.0K	$241.0K
YoY Change	34.16%	5.24%
% of Operating Profit
Other Income/Expense, Net	$5.733M	$4.422M
YoY Change	31.22%	352.15%
Pretax Income	-$11.68M	-$11.25M
YoY Change	-216.09%	-135.94%
Income Tax	-$1.451M	-$2.010M
% Of Pretax Income
Net Earnings	-$10.23M	-$9.240M
YoY Change	-229.34%	-143.25%
Net Earnings / Revenue	-6.16%	-5.7%
Basic Earnings Per Share		-$0.24
Diluted Earnings Per Share	-$0.27	-$0.24
COMMON SHARES
Basic Shares Outstanding	38.38M shares	38.46M shares
Diluted Shares Outstanding		38.49M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$339.6M	$340.9M
YoY Change	-30.59%	-29.37%
Cash & Equivalents	$170.8M	$224.2M
Short-Term Investments	$168.9M	$116.7M
Other Short-Term Assets	$16.20M	$14.80M
YoY Change	122.51%	148.09%
Inventory
Prepaid Expenses	$8.813M	$6.457M
Receivables
Other Receivables
Total Short-Term Assets	$393.7M	$389.9M
YoY Change	-25.32%	-24.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$27.45M	$28.09M
YoY Change	-0.7%	4.72%
Goodwill	$38.05M	$37.91M
YoY Change	0.35%	-0.5%
Intangibles
YoY Change
Long-Term Investments	$78.30M	$80.60M
YoY Change	0.19%	-18.21%
Other Assets	$14.97M	$9.662M
YoY Change	-5.59%	-36.31%
Total Long-Term Assets	$484.7M	$492.3M
YoY Change	1.71%	1.68%
TOTAL ASSETS
Total Short-Term Assets	$393.7M	$389.9M
Total Long-Term Assets	$484.7M	$492.3M
Total Assets	$878.4M	$882.1M
YoY Change	-12.48%	-11.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.126M	$9.200M
YoY Change	-29.03%	-10.13%
Accrued Expenses	$37.46M	$33.60M
YoY Change	-32.28%	-36.91%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$105.3M	$103.4M
YoY Change	-30.75%	-29.52%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$10.69M	$10.33M
YoY Change	24.1%	-2.79%
Total Long-Term Liabilities	$10.69M	$10.33M
YoY Change	24.1%	-2.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$105.3M	$103.4M
Total Long-Term Liabilities	$10.69M	$10.33M
Total Liabilities	$233.1M	$232.8M
YoY Change	-19.66%	-15.64%
SHAREHOLDERS EQUITY
Retained Earnings	$492.3M	$507.0M
YoY Change	-15.93%	-15.45%
Common Stock	$153.7M	$145.2M
YoY Change	16.88%	13.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$645.3M	$649.4M
YoY Change
Total Liabilities & Shareholders Equity	$878.4M	$882.1M
YoY Change	-12.48%	-11.78%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$10.23M	-$9.240M
YoY Change	-229.34%	-143.25%
Depreciation, Depletion And Amortization	$3.315M	$2.400M
YoY Change	2.35%	41.18%
Cash From Operating Activities	$14.68M	$7.700M
YoY Change	-42.2%	-80.78%
INVESTING ACTIVITIES
Capital Expenditures	$1.681M	$2.200M
YoY Change	-45.81%	-162.11%
Acquisitions
YoY Change
Other Investing Activities	-$52.19M	$48.60M
YoY Change	166.49%	68.6%
Cash From Investing Activities	-$53.87M	$46.30M
YoY Change	137.46%	83.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-14.36M	-900.0K
YoY Change	-61.99%	-84.68%
NET CHANGE
Cash From Operating Activities	14.68M	7.700M
Cash From Investing Activities	-53.87M	46.30M
Cash From Financing Activities	-14.36M	-900.0K
Net Change In Cash	-53.54M	53.10M
YoY Change	52.71%	-10.72%
FREE CASH FLOW
Cash From Operating Activities	$14.68M	$7.700M
Capital Expenditures	$1.681M	$2.200M
Free Cash Flow	$13.00M	$5.500M
YoY Change	-41.7%	-87.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Interest Expense InterestExpense	241000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	229000	usd
	us-gaap	Interest Expense InterestExpense	672000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-316000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-965000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	701000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4837000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	717170000	usd
CY2022Q4	us-gaap	Deferred Compensation Cashbased Arrangements Liability Current And Noncurrent DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent	6661000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1741461	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	42.14
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	600138	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	34.30
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	444962	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	41.04
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	10455	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	40.86
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1886182	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	39.92
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	64500000	usd
	mmi	Unrecognized Compensation Expense Is Expected To Be Recognized Over A Weighted Average Period Years UnrecognizedCompensationExpenseIsExpectedToBeRecognizedOverAWeightedAveragePeriodYears	P3Y6M7D
CY2023Q3	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	0	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	115000	shares
	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	0	shares
	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	169000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38492000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40086000	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.24
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.53
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.61
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.40
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38492000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40086000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38740000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40038000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	131000	shares
	mmi	Percentage Of Common Stock Distributed PercentageOfCommonStockDistributed	0.800
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39255838	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39255838	shares
CY2023Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	368000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	649353000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	20397000	usd
CY2022Q3	us-gaap	Dividends Common Stock DividendsCommonStock	10436000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	4544000	usd
CY2022Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	137000	usd
CY2022Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	7577000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	723961000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	713509000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-23101000	usd
	us-gaap	Dividends Common Stock DividendsCommonStock	20372000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	15808000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	392000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4354000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1833000	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	34362000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	649353000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	696304000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	91476000	usd
	us-gaap	Dividends Common Stock DividendsCommonStock	62572000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	12675000	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	414000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	8176000	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1417000	usd
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	7577000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	723961000	usd
	us-gaap	Profit Loss ProfitLoss	-23802000	usd
	us-gaap	Profit Loss ProfitLoss	96313000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10312000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10167000	usd
	mmi	Noncash Lease Expense NoncashLeaseExpense	18824000	usd
	mmi	Noncash Lease Expense NoncashLeaseExpense	17840000	usd
	mmi	Credit Loss Expense Reversal CreditLossExpenseReversal	660000	usd
	mmi	Credit Loss Expense Reversal CreditLossExpenseReversal	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	15808000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	12675000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4915000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2256000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-13000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-1600000	usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-23000	usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	87000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	546000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1459000	usd
	mmi	Increase Decrease In Commissions Receivable IncreaseDecreaseInCommissionsReceivable	6335000	usd
	mmi	Increase Decrease In Commissions Receivable IncreaseDecreaseInCommissionsReceivable	-4891000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2955000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-4544000	usd
	mmi	Increase Decrease In Advances And Loans IncreaseDecreaseInAdvancesAndLoans	9339000	usd
	mmi	Increase Decrease In Advances And Loans IncreaseDecreaseInAdvancesAndLoans	49171000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5371000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	4472000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1872000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4942000	usd
	mmi	Increase Decrease In Income Taxes Receivable Payable IncreaseDecreaseInIncomeTaxesReceivablePayable	722000	usd
	mmi	Increase Decrease In Income Taxes Receivable Payable IncreaseDecreaseInIncomeTaxesReceivablePayable	21106000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-22970000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-15239000	usd
	mmi	Deferred Compensation And Commissions Increase Decrease DeferredCompensationAndCommissionsIncreaseDecrease	-47135000	usd
	mmi	Deferred Compensation And Commissions Increase Decrease DeferredCompensationAndCommissionsIncreaseDecrease	-45481000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-13445000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-14598000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	743000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-994000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-87114000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11775000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	12500000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	175985000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	276708000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	312493000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	266481000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	120000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	71000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	34000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	71000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7689000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8564000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	128733000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-31291000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4354000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	8176000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	392000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	414000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	10439000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	50161000	usd
	mmi	Payments On Stock Appreciation Rights PaymentsOnStockAppreciationRights	1945000	usd
	mmi	Payments On Stock Appreciation Rights PaymentsOnStockAppreciationRights	1761000	usd
	mmi	Principal Payments On Deferred And Contingent Consideration PrincipalPaymentsOnDeferredAndContingentConsideration	2044000	usd
	mmi	Principal Payments On Deferred And Contingent Consideration PrincipalPaymentsOnDeferredAndContingentConsideration	2431000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	34928000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5659000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-53318000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-67774000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-436000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11699000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-111276000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	235873000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	382140000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	224174000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	270864000	usd
	us-gaap	Interest Paid Net InterestPaidNet	423000	usd
	us-gaap	Interest Paid Net InterestPaidNet	599000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	722000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	58572000	usd
	mmi	Increase Decrease In Employee Related Liabilities Noncash IncreaseDecreaseInEmployeeRelatedLiabilitiesNoncash	16000	usd
	mmi	Increase Decrease In Employee Related Liabilities Noncash IncreaseDecreaseInEmployeeRelatedLiabilitiesNoncash	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	259000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	892000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	27669000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	20799000	usd
	mmi	Issuance Of Stock For The Settlement Of Deferred Consideration IssuanceOfStockForTheSettlementOfDeferredConsideration	1833000	usd
	mmi	Issuance Of Stock For The Settlement Of Deferred Consideration IssuanceOfStockForTheSettlementOfDeferredConsideration	1417000	usd
	mmi	Dividends Payable Non Cash Investing And Financing Activity DividendsPayableNonCashInvestingAndFinancingActivity	10555000	usd
	mmi	Dividends Payable Non Cash Investing And Financing Activity DividendsPayableNonCashInvestingAndFinancingActivity	12412000	usd
	mmi	Number Of Offices NumberOfOffices	80	office
	us-gaap	Depreciation Depreciation	6700000	usd
	us-gaap	Depreciation Depreciation	5400000	usd
	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the related disclosures at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to a concentration of credit risk principally consist of cash, cash equivalents, and restricted cash, investments in marketable debt securities, available-for-sale, security deposits (included under other assets, non-current) and commissions receivable, net. Cash, cash equivalents, and restricted cash are placed with high-credit quality financial institutions and invested in high-credit quality money market funds and commercial paper. Concentrations and ratings of marketable debt securities, available-for-sale are limited by the approved investment policy. </span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To reduce its credit risk, the Company monitors the credit standing of the financial institutions money market funds that represent amounts recorded as cash, cash equivalents, and restricted cash. The Company historically has not experienced any significant losses related to cash, cash equivalents, and restricted cash. </span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company entered into a Strategic Alliance (“Strategic Alliance”) with M&T Realty Capital Corporation (“MTRCC”) pursuant to which the Company has agreed to provide loan opportunities that may be funded through MTRCC’s Delegated Underwriting and Servicing Agreement (“DUS Agreement”) with the Federal National Mortgage Association (“Fannie Mae”) that requires MTRCC to guarantee a portion of each loan funded. On a loan-by-loan basis, the Company, at its option, can indemnify a portion of MTRCC’s guarantee obligation of loan opportunities presented to and closed by MTRCC through the DUS Agreement. The Company manages and limits the concentration of risk related to the guarantees assumed by monitoring the underlying property type, geographic location, credit of the borrowers, underlying debt service coverage, and loan to value ratios.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company derives its revenue from a broad range of real estate investors, owners, and users in the United States and Canada, none of which individually represents a significant concentration of credit risk. The Company maintains allowances, as needed, for estimated credit losses based on management’s assessment of the likelihood of collection. For the three and nine months ended September 30, 2023 and 2022, no transaction represented 10% or more of total revenue. Further, while one or more transactions may represent 10% or more of commissions receivable at any reporting date, amounts due are typically collected within 10 days of settlement and, therefore, do not expose the Company to significant credit risk. </span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and nine months ended September 30, 2023, the Company’s Canadian operations represented 5.4% and 4.0% of total revenue, respectively. During the three and nine months ended September 30, 2022, the Company’s Canadian operations represented 1.5% and 2.0% of total revenue, respectively. </span></div>During the three and nine months ended September 30, 2023 and 2022, no office represented 10% or more of total revenue.
	mmi	Period Of Settlement For Receivable Balances PeriodOfSettlementForReceivableBalances	P10D
	us-gaap	Guarantee Obligations Liquidation Proceeds Percentage GuaranteeObligationsLiquidationProceedsPercentage	0.167
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	47839000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	41426000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28088000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27644000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	1700000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	102582000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	375000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	83917000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	4167000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	186499000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	4542000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	209028000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	3501000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	79003000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	2007000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	288031000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	5508000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	usd
CY2022Q3	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	usd
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	usd
CY2022Q3	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	10000	usd
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	23000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	116989000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	116713000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	254683000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	253434000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	55024000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	52633000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	56507000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	54169000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	12293000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	10987000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	13435000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	11850000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	7459000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	6890000	usd
CY2022Q4	mmi	Accrued Sales Commission Non Current AccruedSalesCommissionNonCurrent	45156000	usd
CY2023Q3	us-gaap	Deferred Compensation Cash Based Arrangements Liability Current DeferredCompensationCashBasedArrangementsLiabilityCurrent	431000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	2876000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	2576000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	191765000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	187223000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	327501000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	322029000	usd
	mmi	Available For Sale Securities Weighted Average Maturity AvailableForSaleSecuritiesWeightedAverageMaturity	P1Y10M24D
CY2022	mmi	Available For Sale Securities Weighted Average Maturity AvailableForSaleSecuritiesWeightedAverageMaturity	P1Y1M6D
	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingunit
CY2023Q3	us-gaap	Goodwill Gross GoodwillGross	37909000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	37909000	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	37914000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	37914000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	30884000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16706000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14178000	usd
CY2023Q3	mmi	Intangible Assets Gross Including Goodwill IntangibleAssetsGrossIncludingGoodwill	68793000	usd
CY2023Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	52087000	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y
CY2022	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y6M
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3600000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	37914000	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-5000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1063000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	4022000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	3871000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	2156000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	1855000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1211000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14178000	usd
CY2023Q3	mmi	Advances And Loans And Commissions Receivable Allowance For Credit Loss AdvancesAndLoansAndCommissionsReceivableAllowanceForCreditLoss	762000	usd
CY2022Q4	mmi	Advances And Loans And Commissions Receivable Allowance For Credit Loss AdvancesAndLoansAndCommissionsReceivableAllowanceForCreditLoss	791000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	14796000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	7282000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9662000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15859000	usd
	mmi	Treasury Note Rate Term TreasuryNoteRateTerm	P1Y
CY2023Q3	mmi	Stock Appreciation Rights Liability Current StockAppreciationRightsLiabilityCurrent	2480000	usd
CY2022Q4	mmi	Stock Appreciation Rights Liability Current StockAppreciationRightsLiabilityCurrent	2323000	usd
CY2023Q3	mmi	Stock Appreciation Rights Liability Noncurrent StockAppreciationRightsLiabilityNoncurrent	11228000	usd
CY2022Q4	mmi	Stock Appreciation Rights Liability Noncurrent StockAppreciationRightsLiabilityNoncurrent	13137000	usd
CY2023Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	43028000	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	72247000	usd
CY2023Q3	mmi	Accrued Sales Commission Non Current AccruedSalesCommissionNonCurrent	26575000	usd
CY2023Q3	mmi	Loan Guarantee Obligation Current LoanGuaranteeObligationCurrent	725000	usd
CY2022Q4	mmi	Loan Guarantee Obligation Current LoanGuaranteeObligationCurrent	2040000	usd
CY2023Q3	mmi	Loan Guarantee Obligation Noncurrent LoanGuaranteeObligationNoncurrent	3050000	usd
CY2022Q4	mmi	Loan Guarantee Obligation Noncurrent LoanGuaranteeObligationNoncurrent	0	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	801000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1357000	usd
CY2022Q4	us-gaap	Deferred Compensation Cash Based Arrangements Liability Current DeferredCompensationCashBasedArrangementsLiabilityCurrent	493000	usd
CY2023Q3	us-gaap	Deferred Compensation Cashbased Arrangements Liability Classified Noncurrent DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent	7348000	usd
CY2022Q4	us-gaap	Deferred Compensation Cashbased Arrangements Liability Classified Noncurrent DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent	6168000	usd
CY2023Q3	us-gaap	Other Deferred Compensation Arrangements Liability Current OtherDeferredCompensationArrangementsLiabilityCurrent	204000	usd
CY2022Q4	us-gaap	Other Deferred Compensation Arrangements Liability Current OtherDeferredCompensationArrangementsLiabilityCurrent	258000	usd
CY2023Q3	us-gaap	Other Deferred Compensation Arrangements Liability Classified Noncurrent OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent	0	usd
CY2022Q4	us-gaap	Other Deferred Compensation Arrangements Liability Classified Noncurrent OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent	0	usd
CY2023Q3	mmi	Deferred Compensation And Commissions Current DeferredCompensationAndCommissionsCurrent	46143000	usd
CY2022Q4	mmi	Deferred Compensation And Commissions Current DeferredCompensationAndCommissionsCurrent	75321000	usd
CY2023Q3	mmi	Deferred Compensation And Commissions Non Current DeferredCompensationAndCommissionsNonCurrent	45151000	usd
CY2022Q4	mmi	Deferred Compensation And Commissions Non Current DeferredCompensationAndCommissionsNonCurrent	64461000	usd
CY2023Q3	mmi	Increase Decrease In Carrying Value Of Assets Held In Rabbi Trust IncreaseDecreaseInCarryingValueOfAssetsHeldInRabbiTrust	-237000	usd
CY2022Q3	mmi	Increase Decrease In Carrying Value Of Assets Held In Rabbi Trust IncreaseDecreaseInCarryingValueOfAssetsHeldInRabbiTrust	-347000	usd
CY2023Q3	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-262000	usd
CY2022Q3	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-317000	usd
CY2023Q3	mmi	Deferred Consideration Liabilities Current DeferredConsiderationLiabilitiesCurrent	837000	usd
CY2022Q4	mmi	Deferred Consideration Liabilities Current DeferredConsiderationLiabilitiesCurrent	3633000	usd
CY2023Q3	mmi	Deferred Consideration Liabilities Noncurrent DeferredConsiderationLiabilitiesNoncurrent	725000	usd
CY2022Q4	mmi	Deferred Consideration Liabilities Noncurrent DeferredConsiderationLiabilitiesNoncurrent	1486000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1649000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1726000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4156000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	5341000	usd
CY2023Q3	us-gaap	Dividends Payable Current DividendsPayableCurrent	10438000	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	612000	usd
CY2023Q3	mmi	Dividends Payable Non Current DividendsPayableNonCurrent	1709000	usd
CY2022Q4	mmi	Dividends Payable Non Current DividendsPayableNonCurrent	1603000	usd
CY2023Q3	mmi	Stock Repurchase Payable Current StockRepurchasePayableCurrent	0	usd
CY2022Q4	mmi	Stock Repurchase Payable Current StockRepurchasePayableCurrent	565000	usd
CY2023Q3	mmi	Stock Repurchase Payable Noncurrent StockRepurchasePayableNoncurrent	0	usd
CY2022Q4	mmi	Stock Repurchase Payable Noncurrent StockRepurchasePayableNoncurrent	0	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	687000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	184000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14450000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	9933000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10327000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8614000	usd
CY2023Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	70000000	usd
CY2023Q3	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	0	usd
CY2022Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	70000000	usd
CY2023Q3	mmi	Deferred Consideration Liabilities Current Noncurrent DeferredConsiderationLiabilitiesCurrentNoncurrent	1562000	usd
CY2022Q4	mmi	Deferred Consideration Liabilities Current Noncurrent DeferredConsiderationLiabilitiesCurrentNoncurrent	5119000	usd
CY2023Q3	us-gaap	Deferred Compensation Cashbased Arrangements Liability Current And Noncurrent DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent	7779000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	usd
CY2023Q3	mmi	Business Combination Contingent Deferred Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentDeferredConsiderationArrangementsRangeOfOutcomesValueHigh	16800000	usd
CY2022Q4	mmi	Business Combination Contingent Deferred Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentDeferredConsiderationArrangementsRangeOfOutcomesValueHigh	21300000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	5805000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	8024000	usd
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38546059	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38546059	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39255838	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39255838	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	1098561	shares
	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	34400000	usd
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	31.28
CY2023Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	76000000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3368324	shares
CY2023Q3	mmi	Dividends Payable Non Current DividendsPayableNonCurrent	1700000	usd
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	235000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	85000	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	85000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38492000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40302000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38740000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40358000	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.24
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.61
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.39
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1069000	shares
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1046000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1754000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1041000	shares
CY2023Q3	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	138500000	usd
CY2023Q3	mmi	Maximum Unpaid Loan Amount For Which Guarantee Obligations Granted MaximumUnpaidLoanAmountForWhichGuaranteeObligationsGranted	831200000	usd
CY2023Q3	mmi	Guarantor Obligations Allowance For Loss Sharing Obligations GuarantorObligationsAllowanceForLossSharingObligations	778000	usd
CY2022Q4	mmi	Guarantor Obligations Allowance For Loss Sharing Obligations GuarantorObligationsAllowanceForLossSharingObligations	275000	usd
CY2023Q3	mmi	Guarantor Obligations Amount Pledged GuarantorObligationsAmountPledged	180000	usd
CY2022Q4	mmi	Guarantor Obligations Amount Pledged GuarantorObligationsAmountPledged	16000	usd
CY2023Q3	us-gaap	Other Commitment OtherCommitment	15200000	usd
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001578732-23-000048-index-headers.html	Edgar Link	pending
0001578732-23-000048-index.html	Edgar Link	pending
0001578732-23-000048.txt	Edgar Link	pending
0001578732-23-000048-xbrl.zip	Edgar Link	pending
a10-qmmix20230930x10qxex311.htm	Edgar Link	pending
a10-qmmix20230930x10qxex312.htm	Edgar Link	pending
a10-qmmix20230930x10qxex321.htm	Edgar Link	pending
a101firstamendmenttothes.htm	Edgar Link	pending
a101firstamendmenttothes001.jpg	Edgar Link	pending
a101firstamendmenttothes002.jpg	Edgar Link	pending
a101firstamendmenttothes003.jpg	Edgar Link	pending
a101firstamendmenttothes004.jpg	Edgar Link	pending
a101firstamendmenttothes005.jpg	Edgar Link	pending
a101firstamendmenttothes006.jpg	Edgar Link	pending
a101firstamendmenttothes007.jpg	Edgar Link	pending
a101firstamendmenttothes008.jpg	Edgar Link	pending
a101firstamendmenttothes009.jpg	Edgar Link	pending
a101firstamendmenttothes010.jpg	Edgar Link	pending
a101firstamendmenttothes011.jpg	Edgar Link	pending
a101firstamendmenttothes012.jpg	Edgar Link	pending
a101firstamendmenttothes013.jpg	Edgar Link	pending
a101firstamendmenttothes014.jpg	Edgar Link	pending
a101firstamendmenttothes015.jpg	Edgar Link	pending
a101firstamendmenttothes016.jpg	Edgar Link	pending
a101firstamendmenttothes017.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mmi-20230930.htm	Edgar Link	pending
mmi-20230930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
mmi-20230930_pre.xml	Edgar Link	unprocessable
mmi-20230930_lab.xml	Edgar Link	unprocessable
mmi-20230930_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mmi-20230930_def.xml	Edgar Link	unprocessable
mmi-20230930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MMI
Marcus & Millichap, Inc. Stock $mmi

2023 Q4 Form 10-Q Financial Statement

#000157873223000048 Filed on November 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MMI Marcus & Millichap, Inc. Stock $mmi

2023 Q4 Form 10-Q Financial Statement

#000157873223000048 Filed on November 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MMI
Marcus & Millichap, Inc. Stock $mmi